Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.

DESCRIPTION Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for breast cancer in the general population. METHODS The USPSTF examined the evidence on the efficacy of 5 screening modalities in reducing mortality from breast cancer: film mammography, clinical breast examination, breast self-examination, digital mammography, and magnetic resonance imaging in order to update the 2002 recommendation. To accomplish this update, the USPSTF commissioned 2 studies: 1) a targeted systematic evidence review of 6 selected questions relating to benefits and harms of screening, and 2) a decision analysis that used population modeling techniques to compare the expected health outcomes and resource requirements of starting and ending mammography screening at different ages and using annual versus biennial screening intervals. RECOMMENDATIONS The USPSTF recommends against routine screening mammography in women aged 40 to 49 years. The decision to start regular, biennial screening mammography before the age of 50 years should be an individual one and take into account patient context, including the patient's values regarding specific benefits and harms. (Grade C recommendation) The USPSTF recommends biennial screening mammography for women between the ages of 50 and 74 years. (Grade B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the additional benefits and harms of screening mammography in women 75 years or older. (I statement) The USPSTF concludes that the current evidence is insufficient to assess the additional benefits and harms of clinical breast examination beyond screening mammography in women 40 years or older. (I statement) The USPSTF recommends against clinicians teaching women how to perform breast self-examination. (Grade D recommendation) The USPSTF concludes that the current evidence is insufficient to assess additional benefits and harms of either digital mammography or magnetic resonance imaging instead of film mammography as screening modalities for breast cancer. (I statement).

[1]  D. Berry,et al.  Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. , 2009, Annals of internal medicine.

[2]  H. Nelson,et al.  Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force , 2009, Annals of Internal Medicine.

[3]  Patricia Dolan Mullen,et al.  Client-directed interventions to increase community demand for breast, cervical, and colorectal cancer screening a systematic review. , 2008, American journal of preventive medicine.

[4]  B. Rimer,et al.  Methods for conducting systematic reviews of evidence on effectiveness and economic efficiency of interventions to increase screening for breast, cervical, and colorectal cancers. , 2008, American journal of preventive medicine.

[5]  D. Miglioretti,et al.  Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. , 2007, Journal of the National Cancer Institute.

[6]  K. McMasters,et al.  Trends in mammography and clinical breast examination: a population-based study. , 2007, The Journal of surgical research.

[7]  Eric J Feuer,et al.  The decrease in breast-cancer incidence in 2003 in the United States. , 2007, The New England journal of medicine.

[8]  Douglas K Owens,et al.  Screening Mammography for Women 40 to 49 Years of Age: A Clinical Practice Guideline from the American College of Physicians , 2007, Annals of Internal Medicine.

[9]  Sarah Lord,et al.  When Is Measuring Sensitivity and Specificity Sufficient To Evaluate a Diagnostic Test, and When Do We Need Randomized Trials? , 2006, Annals of Internal Medicine.

[10]  D. Berry,et al.  Effect of screening and adjuvant therapy on mortality from breast cancer. , 2006, The New England journal of medicine.

[11]  C. Baines,et al.  Clinical Breast Examination: Practical Recommendations for Optimizing Performance and Reporting , 2004, CA: a cancer journal for clinicians.

[12]  H. D. de Koning,et al.  Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. , 2004, The New England journal of medicine.

[13]  Roberta M Ray,et al.  Randomized trial of breast self-examination in Shanghai: final results. , 2002, Journal of the National Cancer Institute.

[14]  S. Woolf,et al.  Breast Cancer Screening: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2002, Annals of Internal Medicine.

[15]  A. Berg,et al.  Screening for Breast Cancer: Recommendations and Rationale , 2002, Annals of Internal Medicine.

[16]  Jennifer Spaeth,et al.  Task Force on Community Preventive Services , 2009 .

[17]  R. Birdwell,et al.  Diagnostic Performance of Digital Versus Film Mammography for Breast-Cancer Screening , 2006 .

[18]  V. Semiglazov,et al.  [Results of a prospective randomized investigation [Russia (St.Petersburg)/WHO] to evaluate the significance of self-examination for the early detection of breast cancer]. , 2003, Voprosy onkologii.

[19]  Baines,et al.  Preventive health care , 2001 update : screening mammography among women aged 40 – 49 years at average risk of breast cancer , 2001 .

[20]  S. Fletcher,et al.  The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be done? How? , 1999, JAMA.

[21]  E. J. Smith.  A children's hospital in a medical center , 1947 .

[22]  B. Rimer,et al.  Client-directed Interventions to Increase Community Access to Breast, Cervical, and Colorectal Cancer Screening a Systematic Review , 2022 .